Genetic determinants of survival in patients with Alzheimer's disease

Manuscript Number: 

14-2442R1

Author(s): 
Mahmud M. Barmada, James T. Becker, Steven T. DeKosky, F. Yesim Demirci, Eleanor Feingold, M. Ilyas Kamboh, Oscar Lopez, Robert A. Sweet, Xingbin Wang

Disclosures

Mahmud M. Barmada

  • Lecture Fees:
    Travel/lodging for presentations at Cophenagenomics 2013 (July, 2013) and the European Society of Human Genetics (ESHG) meeting (also July, 2013) - support provided by CLCbio (now Qiagen)

James T. Becker

  • Nothing to Disclose

Steven T. DeKosky

  • Consulting Fees:
    AztraZeneca (consultant for preclinical development of drugs for dementia) Merck (consultant for preclinical development of drugs for dementia) Rivermend (addiction advisory board) Novartis (consultant for preclinical development of drugs for dementia)

F. Yesim Demirci

  • Nothing to Disclose

Eleanor Feingold

  • Nothing to Disclose

M. Ilyas Kamboh

  • Nothing to Disclose

Oscar Lopez

  • Consulting Fees:
    Consultant for Lundbeck and Grifols

Robert A. Sweet

  • Nothing to Disclose

Xingbin Wang

  • Nothing to Disclose